Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

Circulation

Volumn 108, Issue 25, 2003, Pages 3084-3091

  Corrado, Domenico ^a   Leoni, Loira ^a   Link, Mark S ^b   Della Bella, Paolo ^c   Gaita, Fiorenzo ^d   Curnis, Antonio ^e   Salerno, Jorge Uriarte ^f   Igidbashian, Diran ^g   Raviele, Antonio ^h   Disertori, Marcello ⁱ   Zanotto, Gabriele ^j   Verlato, Roberto ^k   Vergara, Giuseppe ^l   Delise, Pietro ^m   Turrini, Pietro ^k   Basso, Cristina ^a   Naccarella, Franco ⁿ   Maddalena, Francesco ^a   Estes III, N A Mark ^b   Buja, Gianfranco ^a   Thiene, Gaetano ^a,o   more..

^a UNIVERSITY OF PADOVA   (Italy)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTRO CARDIOLOGICO MONZINO   (Italy)

^d MAURIZIANO HOSPITAL   (Italy)

^e Spedali Riuniti   (Italy)

^f UNIVERSITY OF INSUBRIA   (Italy)

^g Ospedale Civile   (Italy)

^h Ospedale Umberto I   (Italy)

ⁱ SANTA CHIARA HOSPITAL   (Italy)

^j UNIVERSITY HOSPITAL OF VERONA   (Italy)

^k Ospedale P Cosma   (Italy)

^l Ospedale S Maria del Carmine   (Italy)

^m Ospedale Civile   (Italy)

ⁿ Azienda USL di Bologna   (Italy)

^o Istituto di Anatomia Patologica   (Italy)

more..

Author keywords

Cardiomyopathy; Death, sudden; Defibrillation; Prevention; Tachyarrhythmias

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLECAINIDE; SOTALOL;

ADULT; AGE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; FATALITY; FEMALE; FOLLOW UP; HEART ARREST; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE DYSPLASIA; HEART STIMULATION; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUDDEN DEATH; SURVIVAL RATE; SYNCOPE; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; COMBINED MODALITY THERAPY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 9144273930     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000103130.33451.D2     Document Type: Article

References (22)

1. Marcus FI, Fontaine G, Guiraudon G, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982;65:384-398.
2. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318:129-133.
3. Basso C, Thiene G, Corrado D, et al. Arrhythmogenic right ventricular cardiomyopathy: dysplasia, dystrophy, or myocarditis? Circulation. 1996;94:983-991.
4. Corrado D, Basso C, Thiene G, et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/ dysplasia: a multicenter study. J Am Coll Cardiol. 1997;30:1512-1520.
5. Corrado D, Basso C, Thiene G. Sudden death. In: Nava A, Rossi L, Thiene G, eds. Arrhythmogenic Right Ventricular Cardiomyopathy/ Dysplasia. Amsterdam, Netherlands: Elsevier; 1997.
6. Blomstrom-Lundqvist C, Sabel CG, Olsson SB. Long term follow-up of 15 patients with arrhythmogenic right ventricular dysplasia. Br Heart J. 1987;58:477-488.
7. Marcus FI, Fontaine G, Frank R, et al. Long term follow-up in patients with arrhythmogenic right ventricular dysplasia. Eur Heart J. 1989;10(suppl D):68-73.
8. Corrado D, Basso C, Thiene G. Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart. 2000;83:588-595.
9. Breithard G, Wichter T, Haverkamp W, et al. Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. Am Heart J. 1994;127:1151-1158.
10. Link M, Wang PJ, Haugh CJ, et al. Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibfillator. J Intervent Card Electrophysiol. 1997;1:41-48.
11. Tavernier R, Gevaert S, de Sutter J, et al. Long term results of cardioverter defibrillator in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias. Heart. 2001;85:53-56.
12. Corrado D, Fontaine G, Marcus FI, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Circulation. 2000;101:e101-e106.
13. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J. 1994;71:215-218.
14. Myerburg RJ, Kessler KM, Castellanos A. Recognition, clinical assessment, and management of arrhythmias and conduction disturbances. In: Alexander RW, Schlant RC, Fuster V, eds. Hurst's the Heart. New York, NY: McGraw-Hill; 1998:873-941.
15. Maron BJ, Shen WK, Link MS. et al. Efficacy of implantable cardioverter-ICDs for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000;342:365-373.
16. The Antiarrhythmics versus Implantable defibfillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.
17. Sarter BH, Finkle JK, Gerszten RE, et al. What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction? J Am Coll Cardiol. 1996;28:122-129.
18. Daliento L, Turrini P, Nava A, et al. Arrhythmogenic right ventricular cardiomyopathy in young versus adult patients: similarities and differences. J Am Coll Cardiol. 1995;25:655-664.
19. Thiene G, Basso C, Calabrese F, et al. Pathology and pathogenesis of arrhythmogenic right ventricular cardiomyopathy. Herz. 2000;25:210-215.
20. Fontaine G, Fontaliran F, Andrade FR, et al. The arrhythmogenic right ventricle: dysplasia versus cardiomyopathy. Heart Vessels. 1995;10:227-235.
21. Silka MJ, Kron J, Dunningam A, et al. Sudden cardiac death and the use of implantable cardioverter defibfillator in pediatric patients. Circulation. 1993;87:800-807.
22. Brugada J, Brugada R, Antzelevitch C, et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation. 2002;105:73-78.